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ABSTRACT
Mitochondrial DNA (mtDNA) rearrangements are an
important cause of mitochondrial disease and age
related mitochondrial dysfunction in tissues includ-
ing brain and skeletal muscle. It is known that differ-
ent mtDNA deletions accumulate in single cells, but
the detailed nature of these rearrangements is still
unknown. To evaluate this we used a complemen-
tary set of sensitive assays to explore the mtDNA re-
arrangements in individual cells from patients with
sporadic inclusion body myositis, a late-onset in-
flammatory myopathy with prominent mitochondrial
changes. We identified large-scale mtDNA deletions
in individual muscle fibres with 20% of cytochrome
c oxidase-deficient myofibres accumulating two or
more mtDNA deletions. The majority of deletions re-
moved only the major arc but ∼10% of all deletions
extended into the minor arc removing the origin of
light strand replication (OL) and a variable number of
genes. Some mtDNA molecules contained two dele-
tion sites. Additionally, we found evidence of mito-
chondrial genome duplications allowing replication
and clonal expansion of these complex rearranged
molecules. The extended spectrum of mtDNA rear-
rangements in single cells provides insight into the
process of clonal expansion which is fundamental to
our understanding of the role of mtDNA mutations in
ageing and disease.
INTRODUCTION
Mitochondrial DNA (mtDNA) rearrangements are a com-
mon feature of primarymitochondrial disease due to single,
large-scale mtDNA deletions and diseases due to defects in
mtDNAmaintenance (e.g. POLG,RRM2B) (1,2).MtDNA
rearrangements are also an important cellular feature in
inflammatory diseases such as sporadic Inclusion Body
Myositis (sIBM) andmultiple sclerosis (3), certain neurode-
generative disease such as Parkinson’s disease and in nor-
mal human ageing (4). Despite these observations in-depth
molecular characterization and quantitative survey of large
numbers of cells with rearranged mtDNAmolecules in dis-
ease and ageing has been limited (5). Detailed investigation
of these rearrangements at a single cell and single molecule
level is crucial to elucidate mechanisms of their formation
and accumulation in tissues through clonal expansion.
One of the diseases with the most prominent mitochon-
drial changes is sIBM, a common myopathy of older age,
characterized by inflammatory and degenerative features
in the affected muscle groups (6). The latter include mito-
chondrial histopathological abnormalities which manifest
as diminished respiratory chain function, abnormal prolif-
eration and subsarcolemmal accumulation of mitochondria
(7). Central to sIBMpathogenesis, large-scalemtDNAdele-
tions are considered the major cause of respiratory chain
deficiency with a single type of mutation clonally-expanded
to detrimental levels in individual myofibres (8–10).
There has been a limited number of studies character-
izing mtDNA deletions in sIBM and inflammatory my-
opathies. Oldfors et al. described, for the first time, the pres-
ence of mtDNA deletions in biopsies from three sIBM pa-
tients using in-situ hybridization detecting MT-ND2 and
MT-ND4 transcripts (7). Accumulation of mtDNA dele-
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tions frequently causes respiratory chain deficiency detected
as cytochrome c oxidase (COX) enzymatic deficiency. COX-
deficient myofibres showed normal levels of MT-ND2 (mi-
nor arc locus) while the majority of them showed reduced
hybridization with MT-ND4 (major arc locus) mRNA, in-
dicative of major arc deletions located between the two ori-
gins of replication: Origin of Light and Heavy strand repli-
cation, OL and OH, respectively. A second study from the
same group, using in situ hybridization for MT-ND2, MT-
ND4, MT-ND6 and cytochrome b, confirmed in one more
patient the presence of major arc deletions, which in some
ragged red fibres removedMT-ND4 and in othersMT-ND6
whilst preserving the remaining genes. Polymerase chain
reaction (PCR) analyses of homogenate and single-fibre
DNA extracts further demonstrated these major arc dele-
tions of different sizes (7). To date the largest study of dele-
tions in sIBMsequenced 122 deletion breakpoints and char-
acterized 33 different mtDNA deletions from four patients
(11). The majority of deleted fragments encompassed only
a portion of the major arc of mtDNA (common major arc
deletions) but, interestingly, 6 out of the 33 expanded up to
the OL removing a part of it, and one removed the entire OL
(11).
The major limitation of this and previous studies was
that the primers used for PCR-facilitated detection of dele-
tion species of mtDNAwere flanking OL region, which only
allowed amplification of the major arc deletions. Another
group overcame this problem by using a forward primer
within the D-Loop region and a reverse primer at posi-
tion np14570 (12). Investigation of muscle mtDNA from
two sIBM and one polymyositis patient revealed multiple
deletions, three of which were sequenced. The breakpoints
were located at np1734, np1753 and np3326 demonstrating
mtDNA deletions spanning far into the minor arc of mito-
chondrial genome (12). However, this valuable study screen-
ing the majority of the mitochondrial genome was limited
by the small sample size. In addition, although partial du-
plications of mitochondrial genome have been described in
other conditions with mtDNA deletions (13,14) no studies
to date have investigated mtDNA duplications as possible
rearrangements in muscle from sIBM patients (5).
In view of the limited knowledge of the molecular de-
fects in mtDNA in sIBM, other inflammatory myopathies
and ageing, we identified mtDNA rearrangements in single
muscle fibres from patients with sIBM. We used a highly
sensitive assay based on whole mtDNA genome PCR am-
plification from a single mtDNA molecule template (sm-
PCR) and found that multiple mtDNA deletion species co-
exist in a single myofibre (15). We next applied a newly de-
veloped triplex real-time PCR technique allowing detection
of three mitochondrial targets which revealed that the ma-
jority of these deletions were located within the major arc
of the mitochondrial genome but there were also unusual
deletions extending into the minor arc. Next generation se-
quencing of deletion breakpoints confirmed unusually large
OL-removing molecules and also revealed more complex
mtDNA rearrangements containing two deletions in a sin-
gle molecule. Furthermore, mtDNA duplications were de-
tected in the majority of our patients. This study illustrates
an expanded spectrum of mtDNA rearrangements in hu-
man skeletal muscle in sIBM that may extend to other in-
flammatory and neurodegenerative conditions with mito-
chondrial involvement.
MATERIALS AND METHODS
Patients and muscle biopsies
Open muscle biopsies obtained from nine patients with
sIBM were analysed in this study. All patients had a diag-
nosis of clinically-defined or pathologically-defined sIBM
according to recent criteria (16). All muscle biopsies (eight
from vastus lateralis, one from deltoid) were frozen in liquid
nitrogen-cooled isopentane and stored at −80◦C until pro-
cessed. Additionally, DNA extracted from tissue from two
patients with single, large-scalemtDNAdeletion (muscle), a
patient with epilepsy (brain), a patient with Pearson’s syn-
drome (fibroblasts) (two latter DNA samples were kindly
provided byProfKuntz, Life&BrainCenter, Bonn) and five
healthy individuals (muscle) were used as controls in differ-
ent assays. Basic information about the study participants
and controls is summarized (Table 1). Consent for research
was obtained from all individuals taking part in the study.
Histochemical analysis
Cryostat sections (20 m) were mounted onto superfrost
glass slides or PEN membrane slides (Thermo Fisher) and
dried for 1h at room temperature. Sequential COX and
succinate dehydrogenase (SDH) histochemistry was carried
out to detect respiratory-deficient fibres as previously de-
scribed (17). The stained sections were then used for single-
cell molecular analyses.
Real-time PCR analysis of DNA extracted from single cells
Muscle biopsies from six sIBMpatients, frozen as described
above, served as a source of individual laser-microdissected
myofibres (dissected from 20 m-thick cryosections, pre-
viously labelled for COX/SDH activity, using PALM Mi-
croBeam system, Carl Zeiss) (18). Individual COX-deficient
myofibres (n= 447) were selected for assessment. DNAwas
extracted using QIAamp DNAmicro Kit (QIagen) accord-
ing to the manufacturer’s instructions. Due to very low con-
centration of DNA no quantification was undertaken. De-
tection and quantification of deletion levels were carried
out using triplex (MT-ND4/MT-ND1/D-Loop) real-time
PCR assay (TaqMan) (19) (derived from MT-ND4/MT-
ND1 duplex assay (20,21)) according to the previously
published protocol. Primer and probe sequences are as
follows: MT-ND1 Forward (3485–3504), Reverse (3532–
3553), Probe (3506–3529, VIC-labelled MGB probe); MT-
ND4 Forward (12 087–12 109), Reverse (12 170–12 140),
Probe (12 111–12 138, FAM-labelledMGBprobe); D-Loop
Forward (16 536–16 557), Reverse (34-9), Probe (16 559-6,
NED-labelled, MGB probe) (primer numbers refer to the
mtDNA Genbank reference sequence NC 012920.1). The
25 l reactions consisted of 1X TaqMan Gene Expression
Master Mix, 0.1 M of each probe and 300 nM of each
primer and nuclease-free water. PCR amplification was car-
ried out on StepOnePlus PCR system (Applied Biosystems)
using standard cycling conditions as follows: 95◦C-20 s, 40
cycles of 95◦C-1 s and 60◦C-20 s and data were collected
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Table 1. Characteristics of samples used in the study
Case Patient or Control Sex Age at biopsy [years]
Disease duration at
biopsy [years] Tissue sampled
P1 sIBM M 67 1 Vastus L
P4 sIBM F 79 10 Vastus L
P5 sIBM F 64 3 Vastus L
P6 sIBM F 76 3 Vastus L
P7 sIBM M 48 4 Vastus L
P8 sIBM M 81 3 Vastus L
P9 sIBM F 47 3 Vastus L
P10 sIBM M 69 3 Vastus L
P11 sIBM M 52 3 Deltoid
P13 sIBM M 61 8 Vastus L
s1 single deletion M 44 16 Vastus L
s2 single deletion M 38 unknown Vastus L
c1 epilepsy F 38 unknown Brain
c2 Pearson syndrome F child unknown Fibroblasts
c3 control F 31 N/A Hamstring
c4 control M 47 N/A Hamstring
c5 control F 42 N/A Hamstring
c6 control F 37 N/A Hamstring
c7 control M 40 N/A Hamstring
c8 control M 28 N/A Hamstring
using StepOne software v2.1. Data are presented as the
amount of either MT-ND1 or MT-ND4 in respect to the
amount of D-Loop. Due to double/triple-stranded nature
ofD-Loop regionwe considered samples normal whenMT-
ND1/D-Loop or MT-ND4/D-Loop ratios were between
67% (all mtDNA copies contain triple-stranded D-Loop)
and 100% (all mtDNA copies contain double-stranded D-
Loop). Real-time PCR result was calculated from a stan-
dard curve (seven-point 10-fold dilutions of plasmid p7D1
(19)). Standard curve slopes for all three targets in each ex-
periment never differed by more than 0.05 points and over-
all the slopes were between −3.46 and −3.32 (indicating
PCR amplification efficiency of 94.5 and 100%) with R2 be-
tween 0.9994 and 1. Real-time amplification of single cell-
derived DNA would typically provide CT values between
27 and 33, NTCs would either be undetected or amplify
at >CT 36. Each sample was assessed in triplicate (limited
amount of material did not allow greater repeatability).
Long range PCR
Long range PCR was carried out using LA Taq DNA poly-
merase or PrimeSTAR GXL DNA polymerase (TaKaRa,
Clontech) on DNA samples extracted from individual my-
ofibres and homogenate muscle samples. For ∼16 kb am-
plification of single cell-derived DNA several primer pairs
located in the proximity of the D-Loop region of mtDNA
were used and they are indicated in results Table 4. In case
of homogenate DNA samples, F261 (261–285) and R16291
(16 291–16 267) were used. LATaq reaction (25l) was pre-
pared as follows: 1× buffer, 0.4 Meach of dNTPs, 0.4 M
forward and reverse primers, 0.1 unit polymerase and 1 l
DNA extract and nuclease-free water up to 25 l. Cycling
conditions were: 94◦C-1 min; 35 cycles of 94◦C-30 s, 58◦C-
30 s and 68◦C-16 min; 72◦C-19 min. PrimeSTAR GXL re-
action (25 l) was prepared as follows: 1× buffer, 0.2 M
dNTP mix, 0.4 M forward and reverse primers, 0.625 unit
polymerase and 1 l DNA. Cycling conditions were: 35 cy-
cles of 98◦C-15 s and 68◦C-12 min. For ∼10 kb amplifica-
tion PCR F5855 (5855–5875) and R129 (129–110) primers
were used. Amplified PCRproducts were separated through
0.7–0.9% agarose gels. A DNA sample from a patient with
no evidence of mtDNA rearrangements was used to ensure
full-length amplicons were detected in these assays.
Single molecule long range PCR (smPCR)
Single molecule PCR enables amplification of mtDNA de-
rived from a single copy of mitochondrial genome (15).
Briefly, single muscle fibres were laser dissected from PEN
membrane slides using PALMMicroBeam (Carl Zeiss) and
collected in 10l of lysis buffer ‘ATL’ supplemented with
Proteinase K according to manufacturer’s instructions (QI-
AGEN QIAamp Micro kit). The tubes were centrifuged at
13 000 g for 10 min, incubated at 56◦C for 3 h and DNA
was extracted using affinity columns according to the pro-
tocol. Extracted DNA was then diluted with TE/dH2O
(1/4 ratio) to such a degree that a PCR product was ob-
tained in less than one out of four reactions. smPCR was
carried out in two stages: first round using Phusion Poly-
merase (Thermo Scientific) and second round using LATaq
(TaKaRa, Clontech). Primer pairs used for the first round
were: F2999 (2999–3028) and R2949 (2949–2918) or F2961
(2961–2991) andR2916 (2916–2886) or F130 (130–161) and
R16382 (16 382–16 361). PCR products generated with the
first pair were used with F3160 and R2494 in the second
round of amplification whereas the other pairs were just
used again in the second round. Cycling conditions were as
described above. Amplicons were separated through 0.5%
agarose gels. In all cases the undeleted PCR amplicon (WT)
obtained measured around 16 kb.
Duplication assay
Potential mtDNA duplications or partial duplications were
investigated using a protocol described previously (22).
Briefly, a PCR was carried out using LA Taq polymerase
and the primer pair: 1056F (1056–1075) and 1144R (1144–
1123). Cycling conditions were: 95◦C-2 min; 10 cycles
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of 92◦C-20 s and 68◦C-14 min; 20 cycles of 92◦C-25 s
and 68◦C-16 min; 72◦C-10 min. Samples containing only
wild-type mtDNA molecules generated an 89 bp product,
whereas samples containing duplicated or partially dupli-
cated mtDNA molecules produced a much larger product
or multiple products.
MtDNA deletion breakpoint mapping
In order to map mtDNA deletion breakpoints in smPCR
products, a number of PCRs were designed to identify the
approximate location of a break point. A range of primers
were used to find a pair that would produce a product en-
compassing the break point (‘stepping-in method’). This
product, no larger than 1kb, was then sequenced by conven-
tional Sanger sequencing as described previously (23,24).
The 5′ and 3′ breakpoints were defined as the last nucleotide
present before the deleted region and the first nucleotide
present after the deleted region, respectively. In the situa-
tion when the breakpoints were associated with direct re-
peats the repeat was considered preserved at the 5′ end and
removed from the 3′ end.
MtDNA next generation sequencing
Deep sequencing was used to characterize mtDNA dele-
tion breakpoints in smPCR and long range PCR products.
Briefly, selected amplicons, measuring not more than 9 kb,
were purified using Agencourt AMPure XP reagent and as-
sessed for concentration and quality using Agilent 12 000
DNAkit on a Bioanalyzer (Agilent 2100, Agilent Technolo-
gies). 100ng of eachDNA samplewere taken for long ampli-
con libraries preparation using Ion Xpress Plus Fragment
Library Kit (Thermo Fisher) according to manufacturer’s
instructions. The samples were fragmented using Ion Shear
Plus Enzyme, then ligated to barcoded adapters. Fragments
∼330 bp in length were recovered with E-gel Size Select 2%
gels (Thermo Fisher). The libraries were then amplified and
assessed on a Bioanalyzer using the Agilent High Sensitiv-
ity DNAKit. The libraries were pooled in equimolar ratios
(final concentration 26 pM), then clonally amplified onto
Ion Sphere Particles using the IonOneTouch system and the
Ion OneTouch 200 Template kit v2. Subsequently, the Ion
OneTouch ES Instrument allowed enrichment of template-
positive Spheres, which were then loaded onto an Ion 314
Chip for deep sequencing on the Ion Torrent system.
For breakpoint mapping of single cell samples, data were
analysed using the Torrent Browser (v4.0.2 and above) and
alignments to the human mtDNA reference sequence were
interpreted using IGV (version 2.3; Broad Institute). The
breakpoints were mapped as described in the previous sec-
tion.
For analysis of homogenate muscle DNA samples, we
developed an automated protocol to analyse and ex-
tract breakpoints. In brief, reads were aligned to the hu-
man mtDNA reference sequence using BWA-MEM (25).
Chimeric reads (those aligning to two different parts of the
genome on the 5′ and 3′ end of the read) were identified us-
ing Bioconductor (26) in R (27) and breakpoints identified.
The 5′ breakpoint is reported as the last nucleotide in the
mtDNA molecule before the deleted segment, the 3′ break-
point as the first nucleotide in the mtDNA molecule after
the deleted segment. Breakpoint pairs with a read count un-
der 5 were considered not to represent true deletion break-
points.
RESULTS
Different large-scale mtDNA deletions are detected in muscle
from sIBM patients
Previously, using quantitative duplex real-time PCR (de-
tecting MT-ND1 and MT-ND4 genes), we demonstrated
that 55% of COX-deficient myofibres in sIBM patients har-
boured mtDNA deletions (28). In order to verify and char-
acterize these complex rearrangements, we performed long
range PCR analysis of DNA isolated from individual mus-
cle fibres from 9 sIBM patients using primer pairs designed
to flank the major arc and amplify approximately 10 kb
of wildt-ype mtDNA (Figure 1). Whilst this method is not
quantitative, its high sensitivity allows detection of very low
mtDNA deletion levels (29). We found that in 78 out of
92 (∼85%) COX-deficient cells mtDNA fragments shorter
than the wild type amplicon were generated, confirming
the presence of mtDNA deletions in the majority of sin-
gle biochemically defective cells. The majority of these cells
revealed a single amplified product but, interestingly, 12
cells out of the 78 (∼15%) yielded one or two additional
amplicons indicating the existence of more than one dele-
tion species in a single cell (Figure 1). Furthermore, sizes of
the deleted species varied between individual myofibres ob-
tained from the same muscle biopsy. The majority of COX-
positive cells amplified only a wild-type amplicon, but some
revealed shorter products (cell 2, Figure 1). This observa-
tion demonstrates that low levels of mtDNA deletions are
also present in respiratory-normal cells.
More than one mtDNA deletion accumulates in a single my-
ofibre with a proportion of them being exceptionally large
To verify whether the multiple short PCR products ob-
served in about 15% of deletion-harbouring COX-deficient
myofibres were genuine deletions, we analysed 47 individ-
ual, laser microdissected cells from five cases (‘P1’, ‘P7’,
‘P8’, ‘P9’ and ‘P13’) by single molecule PCR (smPCR) (15).
We used a variety of primer pairs located within the mi-
nor arc, including 2961F and 2916R or 130F and 16382R,
which expanded the analysis beyond the major arc. Repre-
sentative agarose gel electrophoresis images as well as the
position of the primers used in the assay are shown in Fig-
ure 2. On average, 12 PCR-amplified single molecules were
analysed from each cell.We determined that 79% of isolated
muscle fibres contained only one type of deletion, a similar
result to the one obtained using 10 kb long range PCR de-
scribed above (85%). We also found that 17% of the anal-
ysed muscle fibres contained two deleted products of differ-
ent sizes, whilst the remaining 4% contained three types of
deleted mtDNA species.
To determine the exact size of the deletion molecules we
mapped the deletion breakpoints in 20 PCR products from
single molecules (bands marked with ‘1’, ‘2’ etc. in Fig-
ure 2) from three patients (‘P7’, ‘P9’ and ‘P13’) by con-
ventional Sanger sequencing. For molecules ‘7’ and ‘8’,
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Figure 1. Long range PCR analysis of mtDNA from individualmyofibres from a sIBMpatient. A representative agarose gel image of 10-kb long range PCR
analysis of DNA extracted from four individual COX-normal (‘cell 1–4’) and COX-deficient myofibres (‘cell 5–8’) from a sIBM patient (‘P8’) is presented.
A positive control of DNA extracted from whole-blood of a healthy individual (‘c’) was used to ensure detection of full-length amplicons whereas a no-
template (‘nt’) control sample served as a control for contamination. A 10-kb product was amplified with wild-type mtDNA (‘c’) whereas shorter products
were formed with mtDNA molecules harbouring deletions (‘cell1-4’). A single deletion species was found in ‘cell 1’ and ‘cell 2’ (blue arrows) whilst ‘cell 3’
and ‘cell 4’ contained two or three deletions of different sizes respectively (red arrows). The location of the forward (‘F’) and reverse (‘R’) primers used in
the assay (F6358 and R001) is shown in a schematic representation of an mtDNA molecule on the right.
we also verified the breakpoints using next generation se-
quencing. Amongst the 20 PCR products sequenced eight
unique mtDNA deletions were found (bands ‘1–8’, Fig-
ure 2). The location of each deletion is illustrated in Fig-
ure 3. The exact breakpoint positions and sizes of the dele-
tions are specified in Table 2 (nomenclature consistent with
Figures 2 and 3). Only one species of clonally-expanded
mtDNA deletion was found in single cells from patients 13
and 7:‘P13/6’, ‘P13/7’ ‘P7/1’, marked as ‘1’, ‘2’ and ‘3’ re-
spectively (Figure 2). Three muscle fibres dissected from Pa-
tient 9 (‘P9’) demonstrated different scenarios. All of the
mtDNAmolecules from ‘cell 9’ contained an identical dele-
tion (molecule ‘4’, Figure 2); in contrast, both ‘cell 10’ and
‘cell 11’ contained three different deletion species, two of
which were sequenced (‘cell 10’: molecules ‘5’ and ‘6’; ‘cell
11’: molecules ‘7’ and ‘8’, Figure 2) to confirm the existence
of multiple mtDNA rearrangements in a single muscle cell
(Table 2). Intriguingly, six out of the eight deletions detected
removed the origin of light strand replication (OL, np5721-
5781, http://www.mitomap.org/MITOMAP) (‘1’, ‘3’, ‘5’,
‘6’, ‘7’, ‘8’) and four of them either removed a portion of or
the entire MT-ND1 gene (‘3’, ‘5’, ‘6’, ‘7’, ‘8’). Breakpoints
in four of the eight molecules did not occur at sites with re-
peat sequence; the deletion breakpoints in the four remain-
ing molecules were located in regions with either perfect (n
= 3) or imperfect (n= 1) repeats. Repeated sequences varied
from 4 to 11 bp in length (Table 2).
Triplex real-time PCR assay allows detection and quantifica-
tion of the unusual mtDNA deletions
In view of our finding of deletions which remove the MT-
ND1 locus we concluded that the duplex real-time PCR
method we initially used (Rygiel et al. (28)) is not a suit-
able tool for comprehensive detection and quantification of
humanmtDNA deletions. Indeed, the assay can only detect
major arc deletions as it relies upon the preservation ofMT-
ND1.This limitation prompted us to design a triplex real-
time PCRmethod, incorporating amplification of three mi-
tochondrial targets: MT-ND1, MT-ND4 and D-Loop re-
gion (Supplementary Figure S1). This assay enables the de-
tection of unusually large mtDNA deletions with 5′ break-
points located within the minor arc of an mtDNAmolecule
(19). It calculates the level of either MT-ND1 or MT-ND4
relative to the D-Loop region.
Using this method, we analysed a total of 447 laser-
microdissected COX-deficient myofibres from muscle biop-
sies obtained from six sIBM patients (‘P4’, ‘P5’, ‘P7’, ‘P8’,
‘P9’ and ‘P13’, Table 3). We found that 67% of these cells
harboured major arc mtDNA deletions, indicated by the
loss ofMT-ND4 and preservation ofMT-ND1. We also de-
tected 4% of cells with isolated MT-ND1 deletions, where
MT-ND4 was preserved and 4% of cells with deletions en-
compassing both of these genes (low MT-ND1/D-Loop
andMT-ND4/D-Loop ratios). No deletions were detected
in 25% of the assessed myofibres. Individual patients shared
a similar trend in the proportion of the three deletion types
with the major arc deletions being the most frequent. Two
patients (’P9’ and ‘P4’) demonstrated a particularly high
level of combined MT-ND1 and MT-ND4 deletions (9%)
and patient 4 had an exceptionally high (73%) number of
cells in which deletions were not detected (Table 3).
Unusual mtDNA deletions in individual myofibres confirmed
by deep sequencing
To confirm the triplex real-time PCR results we tested sin-
gle cell DNA extracts, identified by this assay as containing
unusual mtDNA deletions (isolatedMT-ND1 deletion and
MT-ND1&MT-ND4 deletion), with whole genome (16 kb)
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Figure 2. Analysis of individual molecules of mitochondrial genome using single molecule PCR amplification. Representative smPCR gel images from
single cell lysates obtained from three sIBM patients (‘P13’, ‘P9’ and ‘P7’), where each amplified product came from a single molecule of mtDNA. In order
to ensure that each amplicon was indeed created from one template, the fraction of positives had to be equal or lower than 0.25 (no more than 1 out of 4
PCR reactions contained a product). Primers hybridizing with the D-Loop region were designed to amplify ∼16 kb of mtDNA and are marked as forward
(‘F’) and reverse (‘R’) in a schematic of mtDNAmolecule on right. One fragment was generated from samples: ‘P13/6’, ‘P13/7’, ‘P9/9’ and ‘P7/1’ signifying
one type of mtDNA deletion (additional smaller amplicons, equidistant from the main amplicon in each lane, are a consequence of mispriming). Samples
‘P9/10’ and ‘P9/11’ both gave rise to three amplicons each indicating three different deletion species per cell (blue horizontal lines indicate different sizes of
individual fragments). All 20 amplicons marked with numbers (‘1–8’) were sequenced using Sanger sequencing, whereas two products ‘7’ and two products
‘8’ were also verified using next generation deep sequencing. Amplicons ‘*’ and ‘#’ were detected by agarose gel electrophoresis but not sequenced.
Table 2. Characterization of mtDNA deletions found using smPCR assay
Nomenclature is maintained throughout the manuscript and figures.
long range PCR and next generation sequencing (Figure 4).
The majority of PCRs produced a single, shorter than wild-
type, product indicating the existence of only one deletion
type per cell. In three out of 16 samples two or three shorter
DNA products were amplified (samples ‘P8/1’, ‘P9/8’ and
‘P13/5’, Figure 4). Deletions detected are graphically pre-
sented in Figure 5 and detailed information regarding exact
breakpoints, primer location and real-time PCR results in
Table 4. In the majority of cases the results obtained us-
ing triplex real-time PCR were reflected in the breakpoint
positions mapped. Samples with both low MT-ND1/D-
Loop and MT-ND4/D-Loop ratios revealed deletions en-
compassing the major and part of the minor arcs, removing
both MT-ND1 and MT-ND4 targets. Almost all samples
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Figure 3. Map of mtDNA deletions. Size and position within the mitochondrial genome of eight types of mtDNA deletions identified by smPCR are
presented as coloured curved lines. Line endings on the left and right mark the 5′ and 3′ breakpoints, respectively. Numbers ‘1–8’ correspond to the
respective PCR amplicons in Figure 2.
Table 3. Frequency of different types of mtDNA deletions found in single myofibres from six sIBM patients using triplex real-time PCR analysis
Case MT-ND4 deletion MT-ND1 deletion
MT-ND1&MT-ND4
deletion Normal Total
Number
of fibres
Percentage of
total [%]
Number
of fibres
Percentage of
total [%]
Number
of fibres
Percentage of
total [%]
Number
of fibres
Percentage of
total [%]
Number
of fibres
Patient 4 4 18 0 0 2 9 16 73 22
Patient 5 44 69 6 9 3 5 11 17 64
Patient 7 4 67 0 0 0 0 2 33 6
Patient 8 43 75 1 2 1 2 12 21 57
Patient 9 58 73 2 3 7 9 13 16 80
Patient 13 147 67 8 4 4 2 59 27 218
All 300 67 17 4 17 4 113 25 447 SUM
harbouring only one species of these ultra-large mtDNA
deletions (‘P9/1-7’ and ‘P5/2’) demonstrated equally de-
creased ratios ofMT-ND1/D-Loop andMT-ND4/D-Loop
ranging from 5 to 70% (Table 4).
Myofibres harbouring several rearranged molecules
(‘P13/1’, ‘P13/2’, ‘P8/1’, ‘P9/8’ and ‘P13/5’) were also typ-
ically in agreement with the quantitative data. In a few
instances the agreement between the breakpoints and the
triplex assay was not definite, possibly reflecting the obser-
vation that multiple deletions can coexist in a single cell.
A good example of that is sample ‘P5/1’, where the only
deletion detected using long-range PCR encompassed both
MT-ND1 and MT-ND4, but real-time PCR analysis re-
vealedMT-ND1/D-Loop andMT-ND4/D-Loop ratios of
49 and 7%, respectively. It is likely that this discrepancy
stands from the presence of another deletion species, with
preserved MT-ND1 and removed MT-ND4, which failed
to amplify using long range PCR. It should be noted that
short major arc deletions are not detectable using the triplex
real-time PCR approach. Analysis of molecule ‘H’ from cell
‘P13/4’, in which neither the MT-ND1 nor the MT-ND4
primer binding sites were deleted, revealed ∼100% MT-
ND1/D-Loop andMT-ND4/D-Loop ratios (Table 4).
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Figure 4. Long range PCR analysis of single myofibre mtDNA. Agarose gel images of 16kb long range PCRs carried out with single cell DNA extracts.
The cells were selected based on triplex real-time PCR results; mostly MT-ND1 and MT-ND1 & MT-ND4 deletions were targeted. Each lane is labelled
with patient number/cell number (e.g. ‘P9/1’) and each amplified PCR product has a unique identifier: ‘A, B, C’ etc. which is maintained throughout the
manuscript. In order to ensure amplification of full-length products with this PCR, whole blood DNA from a healthy individual was used (‘wt’).
Figure 5. Map of mtDNA deletions. Size and position within the mitochondrial genome of 20 types of mtDNA deletions identified by 16-kb long range
PCR are presented as coloured curved lines. Line endings on the left and right mark the 5′ and 3′ breakpoints, respectively. Identifiers ‘A-P3’ correspond
to the respective PCR amplicons in Figure 6.
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Table 4. Characterization of mtDNA deletions detected using single-cell long range PCR assay
Nomenclature is maintained throughout the manuscript and figures.
Mitochondrial genome deletions are more complex than an-
ticipated
Out of the 20 ampliconswe characterized, 15 harboured sin-
gle 5′ and 3′ end breakpoints. In the five remaining ampli-
cons (‘E’, ‘F’, ‘N1’, ‘N2’ and ‘P1’) we identified two 5′ and
two 3′ end breakpoints, all contained seemingly within indi-
vidualmolecules rather than two separate, equally sized am-
plicons, suggesting the occurrence of two deletions in single
mtDNAmolecules (Figure 4, Table 4). These complex rear-
rangements, alongwith the two deletion species identified in
sample ‘P8/1’ (Figure 4 and Table 4), were investigated fur-
ther to establish it they were a real phenomenon or a PCR
artefact.
Molecules ‘E’ and ‘F’, derived from two COX-deficient
myofibres from the same patient (‘P13/1’ and ‘P13/2’, re-
spectively), were found to harbour an identical double dele-
tion. In order to verify this unusual phenomenon, two
stepping-in PCRs were carried out on whole-cell DNA ex-
tracted from each myofibre. Primers were selected to con-
firm deletion location within the genome based on the
PCR amplicon size (Figure 6A). Elongation time was long
enough to facilitate amplification of wild-type molecules.
‘PCR1’, inwhich the primers flanked the outer breakpoints,
resulted in the amplification of a single product of 1246 bp,
consistent with the presence of the two inner breakpoints.
‘PCR 2’, in which the forward primer hybridized with the
stretch of DNA between the inner breakpoints, also gen-
erated amplicons of the expected sizes for double-deletion
(850 bp) andwild-type (6239 bp)mtDNAmolecules (Figure
6B). COX/SDH images of ‘P13/1’ and ‘P13/2’ cells prior
to laser-microdissection are displayed in Figure 6C. Both
PCRs were also performed using five control muscle (‘c1-
c7’, characterized in Table 1) and ‘P13’ homogenate DNA
samples (Figure 6D). Controls ‘c3-c6’ amplified a single
wild-type product in both PCRs, whereas additional shorter
amplicons were generated from ‘c7’. The patient’s DNA
produced multiple products in both PCRs and the wild-
type amplicon was entirely missing from ‘PCR 2’ (Figure
6D). These shorter products indicated mtDNA molecules
with deletions whose breakpoints were contained between
the forward and reverse primers. These shorter amplicons
from ‘c7’ and ‘P13’ samples differed in size and abundance
(‘P13’ revealed markedly more deletion species than ‘c7’).
A similar PCRapproachwas applied to the verification of
the two deletion species (‘M1’ and ‘M2’) identified in sam-
ple ‘P8/1’ (Figure 7A). ‘PCR 3’, with the reverse primer
located within the deleted region of molecule ‘M2’, was
designed to only detect molecule ‘M1’ (651 bp product),
whereas ‘PCR 4’ was designed to amplify both molecules
(736 and 1645 bp products) by placing the reverse primer
upstream of the 3′ breakpoint of ‘M2’ molecule. Results ob-
tained from both PCRs with ‘P8/1’ single cell DNA were
consistent with the existence of two mtDNA deletions (Fig-
ure 7B). Wild-type length amplicons of 7512 and 8506 bp
were generated from control muscle homogenate DNA ‘c5’
in reactions ‘3’ and ‘4’, respectively. These results confirmed
the findings obtained using long range and next-generation
sequencing and also proved to be a useful tool in verifying
complex DNA rearrangements at a single cell level.
The two remaining samples, ‘P9/8’ and ‘P13/5’, were
verified by next-generation sequencing analysis of single-
amplicons derived from whole-cell DNA extracts. Break-
points mapped were identical to the ones obtained previ-
ously using a mixed sample containing two (‘N1’ and ‘N2’)
or three (‘P1’, ‘P2’, ‘P3’) PCR products per tube (Table 4).
Characterization of mtDNA deletions at muscle homogenate
level
Having characterized mtDNA rearrangements in detail us-
ingDNA from single cell or singlemolecule samples we pro-
ceeded to assess DNA extracted from muscle homogenates.
The homogenate-derived DNA samples from two patients
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Figure 6. PCR-based validation of deletion breakpoints. Sequencing of 16kb PCR products ‘E’ and ‘F’ derived from two separate cells from the same
patient (‘P13/1’ and ‘P13/2’) revealed an identical double-deletion in their mitochondrial genome. In order to confirm this phenomenon, stepping-in PCR
was designed. (A) ‘PCR 1’ used primers flanking the outer breakpoints of the double-deletion, as indicated by red arrows. Three possible scenarios were
considered: (i) the double-deletion was real, in which case the expected product would measure 1246 bp; (ii) there was only a single deletion contained
between the outer breakpoints, in which case the product would be 617-bp long; (iii) the PCRwould only generate a wild-type amplicon of 10 449 bp. ‘PCR
2’ used a forward primer binding to the short fragment of DNA in between the inner breakpoints and the same reverse primer as used in ‘PCR 1’ (primers
indicated by green arrows). Again, three scenarios were investigated: (i) the double-deletion was genuine, in which case the product would measure 850
bp; (ii) a single deletion was real, in which case there would be no amplicon as the binding site for the forward primer would have been removed; (iii) only
wild-type would amplify, producing a fragment of 6239 bp. (B) Agarose gel showing amplified products from ‘PCR 1’ and ‘PCR 2’ performed on whole-cell
lysate from ‘P13/1’ and ‘P13/2’. The amplicons are labelled with the molecular sizes expected given identical double-deletion in both molecules. (C) Cells
‘P13/1’ and ‘P13/2’ visualized using COX/SDH histochemistry prior to laser-microdissection for downstream mtDNA analyses. (D) Five healthy control
muscle homogenate DNA samples (‘c3-7’) and homogenate DNA from the same sIBM patient (‘P13’) were subjected to ‘PCRs 1 and 2’. Control samples
‘c3-6’ produced only wild-type amplicons, whereas control ‘c7’ and ‘P13’ produced additional smaller products indicating presence of deleted species of
mtDNA
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Figure 7. Validation of P8/1 single myofibre long-range PCR result. A total of 16-kb long range PCR produced two products from ‘P8/1’ DNA extract
indicating two types of deletion. This was shown by sequencing of the PCR amplicon. In order to validate it further stepping-in PCRmethod was applied.
(A) ‘PCR 3’ used primers flanking the shorter deletion (primers indicated by red arrows). Three outcomes were considered: (i) product of 651 bp as a
consequence of amplification of molecule ‘M1’; (ii) absence of product should molecule ‘M2’ harbour the only genuine deletion in the sample; (iii) a wild-
type product of 7512 bp. ‘PCR 4’ contained primers flanking the larger deletion (green arrows). The possible outcomes were: (i) a single product of 1645 bp
if the only deletion molecule present in the cell was ‘M1’; (ii) two products measuring 1645 and 736 bp if both ‘M1’ and ‘M2’ were present; (iii) wild-type
band of 8506 bp. (B) Agarose gel showing PCR products from ‘reaction 3’ and ‘reaction 4’ carried out using whole-cell lysates from ‘P8/1’ and healthy
control homogenate DNA ‘c5’. The amplicons are labelled with appropriate molecular sizes.
 at U
niversity of N
ew
castle on A
ugust 15, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
5324 Nucleic Acids Research, 2016, Vol. 44, No. 11
(P1 and P5) and two controls (c6 and c8) were subjected
to long range PCR and sequenced using next generation
sequencing. Serially diluted templates were amplified with
the single cell DNA amplification primer pair (F261 and
R16291), which generates ∼16 kb amplicon. Only wild-
type amplicons were amplified from the control samples,
whereas a range of amplicons of variable sizes were gener-
ated from the patients’ samples (Figure 8A). The number of
amplicons varied depending on the initial starting concen-
tration of DNA. Samples with the largest number of ampli-
cons were selected for sequencing. The read depth profiles
of the control samples were highly similar and markedly
different from both patients’ (Figure 8B). The patients’
read depths were clearly diminished in certain areas of the
genome, suggesting deletions. It is interesting to note that
these areas were not identical for patients 1 and 5. Sub-
sequent analysis of the deletion breakpoints revealed no
mtDNA deletions in either of the controls (Supplementary
Figure S2) and 19 and 36 deletions in P1 and P5, respec-
tively (Figure 8C and Supplementary Table S1).
Unusually large mtDNA deletions are accompanied by dupli-
cations
The occurrence of mtDNA deletions removing the origin
of light stand replication (OL) in sIBM muscle fibres is dif-
ficult to explain. One of the potential explanations could
be that they co-exist with duplicated DNA fragments in
which an alternative OL is present allowing for replica-
tion and accumulation of these molecules to detectable lev-
els. We tested this hypothesis by applying an established
PCR-based methodology (22). This assay relies on a pair
of primers strategically located in a region of mtDNA
where the majority of duplication breakpoints are expected
(schematic of a mitochondrial molecule, Figure 9). If one
of more mtDNA duplications are present the PCR gener-
ates a high molecular weight product or multiple products.
Seven sIBM cases for whom muscle homogenate DNA was
available (‘P5’, ‘P6’, ‘P7’, ‘P8’, ‘P10’, ‘P11’ and ‘P13’), two
single, large-scale mtDNA deletion mitochondrial patients
(‘s1’, ‘s2’) and two positive controls from a patient suffering
from epilepsy (‘c1’) and Pearson’s syndrome (‘c2’) (kindly
provided by Zsurka et al. (22)) were tested in multiple inde-
pendent experiments, some of which are presented in Figure
9. Muscle homogenate DNA samples from sIBM cases re-
peatedly revealed a pattern of high molecular weight prod-
ucts indicating multiple mtDNA duplications. Single dele-
tion patients’ samples amplified a single product each sug-
gesting that themtDNAdeletion they harbour coexists with
a duplicated mtDNA region. Control DNA ‘c1’ and ‘c2’
producedmultiple and a single band (as specified by Zsurka
et al., personal communication), as expected from samples
containing either multiple or single rearrangements, respec-
tively.
DISCUSSION
This study carried out an in-depth and detailed charac-
terization of the molecular defects responsible for respira-
tory deficiency in individual myofibres from patients with
sIBM. Complementary techniques enabled us to identify
novel mtDNA rearrangements, expanding the spectrum of
possible mtDNA rearrangements in human skeletal mus-
cle. Consistent with a previous study from Oldfors et al. we
found clonally-expanded, large-scale mtDNA deletions in
COX-deficient fibres (7) but, intriguingly, using long range
PCR and single molecule PCR, we detected several differ-
ent mtDNA deletions coexisting in the same muscle fibre in
15 and 20% of respiratory-deficient cells, respectively. Un-
til recently it has been postulated that a single mitochon-
drial mutation accumulates as a consequence of clonal ex-
pansion and, by reaching a threshold level, results in the
onset of respiratory deficiency (30). Our data show a dif-
ferent scenario in which there may be expansion of several
large-scale mtDNA deletions in a single myofibre, although
one deletion may nevertheless predominate. As sIBM is a
disease characterized by multiple large-scale mtDNA dele-
tions we hypothesized that these findings would relate to a
range of other neuromuscular conditions in which similar
mtDNA pathology is present. Indeed we provide evidence
that the nature of mtDNA rearrangements we identified in
sIBM is not limited to this disease but it occurs inmitochon-
drial DNA maintenance disease which results in multiple
mtDNA deletions accumulating in the muscle (Supplemen-
tary Figure S3A). It is likely that other inflammatory and
degenerative diseaseswithmitochondrial involvement share
a similar pattern.
It is interesting that at least some forms of hereditary
IBM (hIBM) have been shown to present with multiple
mtDNA deletions in myofibres (31,32). This finding to-
gether with disorders in which multiple mtDNA deletions
are a consequence of mutations in nuclear genes engaged in
mitochondrial genome maintenance may suggest a nuclear
genetic background as underlying mechanism of mtDNA
rearrangements formation and accumulation. A number of
candidate genes involved in mtDNA replication and main-
tenance, including Twinkle, POLG and RRM2B, have been
investigated in sIBM patients but the variants found could
neither explain the mtDNA rearrangements nor the respi-
ratory deficiency in sIBM (33). Further work involving a
broader spectrum of genes is needed to formulate a conclu-
sion whether it is the genetic predisposition, environmental
factors or a combination of both that triggers mtDNA re-
arrangements in this disease.
Further characterization of mtDNA deletions in sIBM
at a single cell and homogenate level revealed that in a pro-
portion of fibres the 5′ breakpoint was placed beyond OL
and in some cases the deleted region stretched far into the
minor arc. Additionally, we detected similar deletions in
a patient with mtDNA maintenance disease (Supplemen-
tary Figure S3B). This phenomenon of exceptionally large
mtDNA deletions, although rare, has been described in lit-
erature in other circumstances including physiological age-
ing. Using in situ hybridization, Lee et al. reported mtDNA
deletions removingOL in 4 out of 26COX-deficient, ragged-
red fibres from senescent monkeys (44). This was later con-
firmed by PCR analysis and sequencing of DNA from sin-
gle laser-microdissected cells (45). That study showed that
nearly one-third of the genomes had lost OL and a variable
portion of the minor arc. Likewise, in healthy human tissue
(heart, diaphragm and skeletal muscle) more than half of
over 50 clonally-expanded mtDNA deletions removed OL
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Figure 8. Detection of mtDNA deletions in homogenate DNA samples by next generation sequencing. (A) DNA extracted from ten 20-mmuscle cryosec-
tions from two sIBM patients (P1 and P5) and two controls (c6 and c8) was subjected to long range PCR. For the patients, four serial dilutions were used in
four reactions to find the concentration that would result in the highest number of amplicons. Selected samples are depicted by red arrows. The schematic
on the right shows position of PCR primers used (261F and 16291R). (B) Graphical representation of read depth for all sequenced samples. Both controls
show almost identical peaks and troughs, whereas the patients differ from controls and one another. Low read depth, clearly visible in certain areas of the
mitochondrial genome, indicates mtDNA deletions (depicted by red arrows). (C) Graphical representation of all deletions detected in the patients’ mtDNA
by analysis of chimeric sequencing fragments. Each horizontal bar shows the deleted portion of the mtDNA genome as represented by the chimeric reads
that align to two distinct parts of the mtDNA reference sequence. The x axis shows the nucleotide position on the mitochondrial genome (0–16 569 bp).
The y axis depicts cumulative read count, with individual reads ordered from top to bottom by 5’ and then 3’ breakpoints. All chimeric reads are depicted;
those in grey have read counts below 5 and are unlikely to represent deletion species. All other multiple read deletions are colour coded for clarity, with
breakpoints annotated on both the main figure and in the legend and the height of each bar representing the read count.
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Figure 9. Assessment of duplications of mitochondrial genome. Duplication PCR assay was carried out using 1056F forward (‘F’) and 1144R reverse (‘R’)
primers (schematic of mtDNA molecule) on muscle homogenate DNA samples available from seven sIBM patients (‘P5’, ‘P6’, ‘P7’, ‘P8’, ‘P10’, ‘P11’ and
‘P13’). Two control DNA samples known to contain duplications (‘c1’ and ‘c2’) and two samples from patients with single mtDNA deletion (‘s1’ and ‘s2’)
were also tested. Agarose gels from several independent experiments are presented. Large products indicate presence of duplicated or partially-duplicated
mitochondrial genomes.
(41). Interestingly, studies involving skeletal muscle from
aged rodents did not detectmtDNAmolecules devoid ofOL
(34), potentially suggesting inter-species differences in the
mechanisms underlying mtDNA deletion formation. This,
however, requires detailed investigation.
Nevertheless, there is scarce evidence supporting preva-
lence of such OL-devoid deletions in human diseases such
as sIBM. The only two studies reporting their occurrence
are limited by low sample size or the PCR primers used
for detection of the deletions (11,12). The four deletion
breakpoints these studies characterized: np1741, np1753
(12) and np5561, np5745 (11) were not found in our sam-
ples. The closest deletion sites were: np1487 and np1500 as
well as np5787 and np5788. We first detected these unusual
deletion species by sequencing smPCR products and found
that six out of eight molecules lacked OL. We concentrated
our analyses on smaller products because we suspected
they could represent atypical mtDNA rearrangements. As
a result, these data do not reflect the true prevalence of
these deletions in a population of COX-deficient myofibres.
Our triplex real-time PCR-based approach, on the other
hand, enabled quantitative assessment of the prevalence of
OL-eliminating deletions. We tested nearly 500 respiratory-
deficient myofibres and demonstrated that approximately
8% of them harboured OL-eliminating mtDNA deletions
spanning up to at least the MT-ND1 gene locus (primer
binding site). We also note that this figure may be an un-
derestimation of the total number of minor arc deletions as
this assay does not detect deletions with a 5′ breakpoint lo-
cated between OL andMT-ND1 probe/primer binding site.
Intriguingly, a few of the deletion species we detected
contained four breakpoints indicating presence of two dele-
tions in a single molecule. These complex rearrangements
of mtDNAwere detected in 5 out of 28 molecules subjected
to whole mitochondrial genome sequencing. A similar un-
usual rearrangement of the mitochondrial genome was pre-
viously reported by Cao et al. in a single ragged red my-
ofibre from a senescent rat (34). The authors identified an
mtDNA molecule harbouring several breakpoints and dis-
ordered sequence between them. In our study all of the com-
plex molecules harboured two deletions with preserved se-
quence in between. The majority of deletion molecules de-
tected in this study were different in individual cells but we
found two pairs of myofibres containing identical deletion
patterns. One pair harboured a single deletion with break-
points at np3325-13 923 and the other a double deletion
(np1344-5161 and np5787-11 178).
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Existence of these unusual mtDNA deletions is challeng-
ing to explain. OL has been shown essential for mtDNA
replication (35) yet a number of molecules lacking OL are
detectable in cells. An alternativemtDNA replicationmodel
known as strand-coupled replication could take place in
myofibres and lead to accumulation of these OL-devoid
deletions (36). Another way these species could replicate is
if they are contained within partially duplicated mtDNA
molecules, where OL is preserved within the duplicated re-
gion. MtDNA duplications have been reported in a num-
ber of disorders including single mtDNA deletions (13),
diabetes mellitus (37), Kearns-Sayre syndrome (14), Pear-
son syndrome (38,39) and adult-onset progressive myopa-
thy (40). Collectively, duplications have been found in over
50% of single mtDNAdeletion conditions to date (5). Inter-
estingly, duplications have also been found in skeletal mus-
cle from healthy older adults. PCR analysis of OL-lacking
clonal mtDNA molecules revealed that these were in fact
partially duplicatedmolecules, with a deleted genome incor-
porated in a wild-type molecule (41), although the mecha-
nisms underlying such rearrangements remain unclear. Tan-
dem duplication and triplication of an mtDNA segment
was also reported in the muscle of a healthy elderly man
(42). In this study we demonstrate the existence of dupli-
cated mitochondrial genomes in muscle from sIBM pa-
tients. All of the tested sIBM cases harboured multiple du-
plicated fragments in muscle homogenates. As a control, we
used samples from three patients harbouring single, large-
scale mtDNAdeletions, which all demonstrated a single du-
plicated mtDNA product as expected, and a sample from a
previously characterized patient with epilepsy which con-
tained multiple duplications. We did not detect any dupli-
cations in five young healthy control muscle samples.
A strikingly similar pattern of deletion/duplication
breakpoints was reported in muscle from patients with
MGME1 mutation (22), with the difference that the abso-
lutemajority of rearrangements found there were within the
minor arc. In both sIBM andMGME1, distinct breakpoint
hotspots exist around tRNALeu gene (np3230–np3304) at
the 5′ end and position np16070 at the 3′ end. In sIBM the
5′ breakpoint of nine out of 28 molecules clustered between
np3263 and np3393 and five had ∼np16070 breakpoint but
there were also two additional hotspots: ∼np13923 (nine
molecules) and ∼np12300 (four molecules). It is interest-
ing to note that the region np16 001–16 100 is a hotspot
for breakpoints in patients with multiple mtDNA deletions,
sIBM and healthy ageing in contrast to patients with sin-
gle deletions including Progressive External Ophthalmo-
plegia (PEO), Kearns-Sayre Syndrome (KSS) and Pear-
son Syndrome (PS), who do not harbour deletion break-
points in that region (5). A case study on skeletal mus-
cle from a healthy 57 year old man demonstrated par-
tial triplication of mtDNA with deletion breakpoints lo-
cated at np3263-3272 and np16 065–16 076 (42). Non-
pathogenic mtDNA deletions called sublimons character-
ized in healthy, mostly cardiac, tissue contained a similar
breakpoint pattern: ∼np3260 and ∼np16070 (43). Dele-
tions identified in two homogenate DNA patient samples
by next generation sequencing revealed similar hotspots;
some present in both and others only in one of them. Al-
though this PCR amplification-based method is unsuitable
for quantifying abundance of different deletions in a sam-
ple, it identifies a wide range of them. The 5′ breakpoints
located at np3200-3300 were common in P5 and absent in
P1, whereas breakpoints at ∼np5780 predominated in P1
and were not detected in P5. Similarly, 3′ breakpoints at
∼np13923 were identified only in P1 and ∼np12300 only in
P5. The breakpoints common to both patients were located
around np5780 and np16 070.
Analysis of DNA sequences flanking the breakpoints
in this study provided variable results. Some breakpoints
were associated with perfect repeats measuring from four to
13bp, some had imperfect repeats up to 19 bp but the ma-
jority did not have any repeated sequences. It is difficult to
stipulate a mechanism underpinning deletion/duplication
formation in sIBM at this stage and further investigation
needs to be carried out to address that.
This study has demonstrated that mtDNA rearrange-
ments are substantially more complex than previously as-
sumed. We used a single-cell approach with a combina-
tion of real-time PCR, long range PCR, single molecule
PCR and whole mitochondrial genome sequencing to in-
vestigate a large number of samples from nine sIBM pa-
tients. Overall, our data provide strong evidence for the
existence of multiple deletion species in single respiratory-
deficient myofibres, as well as complex rearrangements re-
sulting in mtDNAmolecules which (i) lack OL, (ii) harbour
double-deletions and (iii) contain partial duplications. We
also quantified the prevalence of different deletion types in
a large population of COX-deficient muscle fibres, provid-
ing estimates of their abundance. These novel findings thus
unearth an expanded spectrum of mtDNA rearrangements
in sIBM, which could extend to other inflammatory and
degenerative conditions with knownmitochondrial involve-
ment and in nuclear mutation-associated mtDNA mainte-
nance disorders and ageing itself. Our data obtained from
three cases of nuclear mutation-associated mtDNA disor-
ders demonstrate presence of multiple mtDNA deletions in
individualmyofibres, with some of them exceptionally large,
OL-removing and strikingly similar to the ones we have de-
scribed in sIBM (Supplementary Figure S3). More work
carried out on specific cohorts of individuals affected with
inflammatory, metabolic and defined genetic conditions is
required to reveal the mechanisms by which these complex
rearrangements occur, the process driving their accumula-
tion in individual cells and their pathophysiological signifi-
cance.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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